Kok-Seong Lim | Principal, Eight Crest Strategies
Independent Expert

Kok-Seong Lim, Principal, Eight Crest Strategies, Independent Expert

Kok Seong Lim, BPharm, PhD, RAC, is Founder and Principal of Eight Crest Strategies, a CMC, technical and regulatory advisory for biologics, cell therapy, gene therapy and gene-editing programs. He has more than 20 years in biologics research and development, specializing in CMC, analytical sciences, quality control and regulatory strategy for advanced therapy platforms. He has held leadership positions at Metagenomi, Aura Biosciences, Editas Medicine and Thermo Fisher Scientific, helping advance more than 15 advanced therapy programs across gene therapy, cell therapy and gene editing. That work has spanned AAV, retroviral and adenoviral vectors, mRNA and guide RNA, lipid nanoparticles, Cas enzymes and oligonucleotides, for rare disease and oncology indications including hemophilia, retinal and optic-nerve disorders, and lysosomal storage disease. He has built analytical and quality organizations of 15 to 20 scientists, established GMP manufacturing and analytical infrastructure from the ground up, managed multimillion-dollar portfolios, and contributed to the CMC content behind regulatory submissions and health-authority interactions in the U.S. and Europe. An active contributor to the biotechnology and regulatory communities, he serves as a member of the U.S. Pharmacopeia Biologics - Cell and Gene Therapy Expert Committee, as a U.S. Technical Advisory Group member and working-group expert for ISO/TC 276, and as Chair of the Regulatory Affairs Professionals Society San Francisco Bay Area Chapter, developing the standards and expectations that advanced therapies are measured against. He earned his PhD in Biochemistry from the National University of Singapore and a BSc in Pharmacy from the University of Strathclyde, and conducted postdoctoral research at MIT and UC San Diego.

Appearances:



Festival of Biologics Day 2 @ 15:40

Panel Discussion: From Bench to Bedside: Overcoming CGT Commercialization Hurdles

last published: 18/Nov/26 17:29 GMT

back to speakers

Get involved at Festival of Biologics USA 2027

 

 

TO SPONSOR


Nicholas Matthews

Nicholas.Matthews@terrapinn.com

 

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

Ollie.Mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.